spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

dorost

J&J’s experimental psoriasis drug shows promise against Bristol’s treatment

Johnson & Johnson said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers...

Lilly trial shows weight loss with experimental pill flattens over time

Eli Lilly’s Nexperimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for...

SPIMACO secures $53.3mln financing from Saudi National Bank

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) has secured a short-term SAR 200 million ($53.3 million) loan from...

US weighs Trump-branded website to help shop for cheaper drugs, Bloomberg News reports

U.S. officials are considering a website, possibly named after President Donald Trump, to help patients buy discounted prescription drugs...

Lilly’s GLP-1 Pill Beats Older Novo Diabetes Drug in Head-to-Head Trial

Patients on Eli Lilly & Co.’s experimental diabetes pill lost more weight and had better blood sugar control than...

Arvinas Transfers Commercial Rights of Experimental Breast Cancer Drug to Third Partner

Arvinas announced that it has transferred the commercial rights of its experimental breast cancer drug, vepdegestrant, developed in collaboration...
spot_imgspot_img

Roche to Acquire Liver Drug Developer 89bio for up to $3.5 Billion

Roche has agreed to buy U.S. biotech firm 89bio for up to $3.5 billion to strengthen its development pipeline...

Health Rounds: Laser surgery safe for nearsighted teens, study shows

-Laser surgery for nearsightedness is as safe and effective in older teenagers as it is in adults, researchers reported...

Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

Novo Nordisk's experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The...

Regeneron’s rare bone disorder drug succeeds in late-stage trial

Regeneron Pharmaceuticals said on Wednesday its experimental treatment for a rare genetic disorder affecting soft tissue significantly reduced abnormal...

Over half of US healthcare workers plan to switch jobs by next year, survey finds

More than half of U.S. healthcare workers are actively looking to leave their current jobs, according to a new...

Lilly weight-loss pill could be FDA-approved by year-end

Eli Lilly (LLY.N), opens new tab's experimental weight-loss pill could be fast-tracked under a one- to two-month review process...